AirSculpt Technologies, Inc. (NASDAQ:AIRS) Short Interest Down 28.9% in December

AirSculpt Technologies, Inc. (NASDAQ:AIRS) saw a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 3,416,693 shares, a drop of 28.9% from the November 30th total of 4,804,380 shares. Approximately 23.4% of the company’s shares are short sold. Based on an average daily volume of 683,627 shares, the days-to-cover ratio is currently 5.0 days. Based on an average daily volume of 683,627 shares, the days-to-cover ratio is currently 5.0 days. Approximately 23.4% of the company’s shares are short sold.

AirSculpt Technologies Trading Down 6.5%

NASDAQ AIRS opened at $2.03 on Monday. AirSculpt Technologies has a 52 week low of $1.53 and a 52 week high of $12.00. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.51 and a current ratio of 0.51. The stock’s 50 day moving average price is $5.47 and its two-hundred day moving average price is $6.06. The stock has a market capitalization of $126.75 million, a price-to-earnings ratio of -6.77 and a beta of 2.63.

AirSculpt Technologies (NASDAQ:AIRS) last issued its quarterly earnings results on Friday, November 7th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.03). AirSculpt Technologies had a negative net margin of 11.41% and a negative return on equity of 14.30%. The business had revenue of $34.99 million during the quarter, compared to analyst estimates of $39.80 million. As a group, analysts anticipate that AirSculpt Technologies will post -0.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on AIRS. Leerink Partners reaffirmed a “market perform” rating and set a $6.00 price objective on shares of AirSculpt Technologies in a research note on Tuesday, November 11th. Weiss Ratings restated a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 22nd. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus price target of $5.50.

Hedge Funds Weigh In On AirSculpt Technologies

A number of large investors have recently made changes to their positions in the company. Larson Financial Group LLC raised its position in shares of AirSculpt Technologies by 20.4% in the third quarter. Larson Financial Group LLC now owns 15,137 shares of the company’s stock valued at $121,000 after buying an additional 2,561 shares in the last quarter. Wexford Capital LP increased its stake in AirSculpt Technologies by 2.6% during the 3rd quarter. Wexford Capital LP now owns 102,614 shares of the company’s stock worth $823,000 after acquiring an additional 2,614 shares during the period. Rhumbline Advisers raised its holdings in AirSculpt Technologies by 16.1% in the 3rd quarter. Rhumbline Advisers now owns 20,782 shares of the company’s stock valued at $167,000 after acquiring an additional 2,876 shares in the last quarter. Creative Planning lifted its position in shares of AirSculpt Technologies by 32.2% during the 2nd quarter. Creative Planning now owns 13,225 shares of the company’s stock valued at $64,000 after acquiring an additional 3,224 shares during the period. Finally, BNP Paribas Financial Markets lifted its position in shares of AirSculpt Technologies by 239.5% during the 3rd quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock valued at $48,000 after acquiring an additional 4,199 shares during the period. Institutional investors own 91.54% of the company’s stock.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.